Piomic Medical, headquartered in Zurich, Switzerland with a U.S. subsidiary in Chicago, is a medtech startup and pioneer in the development of innovative medical devices for the treatment of chronic and acute wounds.In late 2022 the U.S. Food and Drug Administration (FDA) fully approved Piomic’s Investigational Device Exemption (IDE) application for MAVERICKS, the COMS® One therapy system pivotal trial in patients with refractory diabetic foot ulcers.The COMS® One therapy system was awarded CE Mark Approval in May 2020 and is commercially available in select global markets during an initial soft launch phase.

Led commercial efforts and provided daily operational leadership for a U.S. subsidiary of a Taiwanese medical device manufacturer in wound care. Served customers throughout North America for OEM and ODM decubitus ulcer and lymphedema management products.

Drove strategy, revenue growth and overall P&L improvements for an equity-owned, respected leader in wound prevention and healing, surgical supplies and consumer products. Served a diverse mix of customers, including hospitals, nursing homes (SNFs), physicians, durable medical equipment suppliers (DMEs), MedSurg partners, international distributors (Canada, Europe, Latin America, Asia), colleges and universities, and key OEM and CM customers. Company was acquired by Hill-Rom in 2016 and fully integrated by the end of 2018.

Led a top-performing U.S. commercial team that included outside and inside sales, marketing, customer service, key account management and field service personnel. Served a global customer base with a mix of organically developed and contracted products. Promoted to President & CEO, while retaining the primary responsibilities involved in sales and marketing leadership.

Increased revenue, distribution and clinical applications for a novel regenerative medicine technology platform. Delivered results through individual and team contribution in a resource-constrained, entrepreneurial startup environment.

Provided commercial and general management leadership for a standalone business unit serving customers in North America and Latin America. Accountable for strategic direction, sales and marketing, manufacturing, quality, medical oversight, clinical research and the divisional P&L. Maintained dual reporting to U.S. and Swiss leadership in a matrix organizational structure.

Established a sustainable new business unit through steady sales growth, milestone achievement, effective communication and comprehensive planning at the corporate and business levels.

Created and executed sales and marketing plans for existing product lines, while simultaneously developing new products, markets and channels for planned expansion.